TLX
#1544
Telix Pharmaceuticals Limited - American Depositary Shares
11.2 7 USD
-0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-0.97%
Changement Mensuel
+9.63%
Evolution sur 6 mois
+60.09%
Changement Annuel
+78.61%
Clôture Précédente
11.3 8
Open
11.2 9
Low
11.2 7
High
11.3 0
Volume
40
Financials
- Market Capitalization 3.82 B
- Employee 1 184
- Founded 2015
- CEO Christian Behrenbruch
- Website www.telixpharma.com
- Headquarter Australia
- FIGI BBG01N69K900
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1534 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.74 USD | -6.56% | -10.09% | +78.15% | +267.62% | 3.87 B USD | ||
| 1542 |  DNLI Denali Therapeutics Inc. - Common Stock | 24.01 USD | -2.68% | -3.65% | +0.54% | +48.48% | 3.84 B USD | ||
| 1558 |  VKTX Viking Therapeutics, Inc. - Common Stock | 32.15 USD | -5.05% | -5.13% | -5.02% | +16.23% | 3.75 B USD | ||
| 1563 |  RCUS Arcus Biosciences, Inc. Common Stock | 29.19 USD | -4.61% | -4.30% | +6.18% | +173.57% | 3.72 B USD |